RecruitingNot ApplicableNCT06166953
The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled Study
The Effect of Digital Technology-Supported Education and Monitoring on Anxiety, Pain, Sleep and Quality of Life in Patients Undergoing Immediate Breast Reconstruction After Mastectomy: A Randomized Controlled Study
Sponsor
Baskent University
Enrollment
38 participants
Start Date
Sep 27, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this randomized, controlled study is to test the effectiveness of digital technology-supported education on patients undergoing breast reconstruction after mastectomy.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria8
- Being diagnosed with stage 1, 2, or 3 breast cancer
- Planned to undergo immediate breast reconstruction after mastectomy for the first time
- Being between 18 to 75 years old
- Able to use smart phone
- Having smart phone with Android v5.0 or iOS v9.0 and above software, Bluetooth and internet connection
- Having no hearing or visual impairment
- Having no physical limitation
- Turkish speaking volunteers
Exclusion Criteria1
- Patients planned to undergo total abdominal hysterectomy and bilateral salpingo oophorectomy with immediate reconstruction after mastectomy
Interventions
OTHERdigital technology-supported education
The education will include information about surgical process and care after surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06166953
Related Trials
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer
NCT073490692 locations
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
NCT074245475 locations
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
NCT0722226712 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids
NCT050073791 location